HomeBDTX • NASDAQ
add
Black Diamond Therapeutics Inc
Previous close
$2.75
Day range
$2.71 - $2.82
Year range
$1.20 - $4.94
Market cap
159.80M USD
Avg Volume
1.47M
P/E ratio
7.68
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.98M | -39.45% |
Net income | -8.50M | 45.38% |
Net profit margin | — | — |
Earnings per share | -0.15 | 46.43% |
EBITDA | -10.89M | 39.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 135.50M | 20.25% |
Total assets | 157.73M | 14.39% |
Total liabilities | 31.58M | -21.96% |
Total equity | 126.15M | — |
Shares outstanding | 56.97M | — |
Price to book | 1.24 | — |
Return on assets | -16.93% | — |
Return on capital | -18.35% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.50M | 45.38% |
Cash from operations | -7.85M | 30.67% |
Cash from investing | 8.59M | 291.70% |
Cash from financing | 134.00K | 153.17% |
Net change in cash | 874.00K | 109.32% |
Free cash flow | -5.74M | 4.94% |
About
Founded
2014
Website
Employees
24
